Literature DB >> 15752053

Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers.

Olga Garbuzenko1, Samuel Zalipsky, Masoud Qazen, Yechezkel Barenholz.   

Abstract

The electrostatics of large unilamellar vesicles (LUVs) of various lipid compositions were determined and correlated with steric stabilization. The compositional variables studied include (a) degree of saturation, comparing the unsaturated egg phosphatidylcholine (EPC) and the fully hydrogenated soy phosphatidylcholine (HSPC) as liposome-forming lipids; (b) the effect of 40 mol % cholesterol; (c) the effect of mole % of three methyl poly(ethylene glycol) (mPEG)-lipids (the negatively charged mPEG-distearoyl phosphoethanolamine (DSPE) and two uncharged lipopolymers, mPEG-distearoyl glycerol (DSG) and mPEG-oxycarbonyl-3-amino-1,2-propanediol distearoyl ester (DS)); and (d) the negatively charged phosphatidyl glycerol (PG). The lipid phases were as follows: liquid disordered (LD) for the EPC-containing LUV, solid ordered (SO) for the HSPC-containing LUV, and liquid ordered (LO) for either of those LUV with the addition of 40 mol % cholesterol. The LUV zeta potential and electrical surface potential (psi(0)) were determined. It was found that progressive addition of mPEG(2k)-DSPE to liposomes increases negative surface potential and reduces surface pH to a similar extent as the addition of PG. However, due to the "hidden charge effect", zeta potential was more negative for liposomes containing PG than for those containing mPEG(2k)-DSPE. Replacing mPEG-DSPE with mPEG(2k)-DS or mPEG-DSG had no effect on surface pH and surface potential, and zeta potential was approximately zero. Addition of low concentrations of cationic peptides (protamine sulfate and melittin) to PG- or mPEG-DSPE-containing liposomes neutralized the liposome negative surface potential to a similar extent. However, only in liposomes containing PG, did liposome aggregation occur. Replacing the negatively charged lipopolymer mPEG-DSPE with the neutral lipopolymers mPEG-DS or mPEG-DSG eliminates or reduces such interactions. The relevance of this effect to the liposome performance in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752053     DOI: 10.1021/la0479105

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  20 in total

1.  PEG-stabilized micellar system with positively charged polyester core for fast pH-responsive drug release.

Authors:  Hua-Fen Wang; Hui-Zhen Jia; Si-Xue Cheng; Jun Feng; Xian-Zheng Zhang; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2012-01-21       Impact factor: 4.200

2.  Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.

Authors:  Shanthi Ganesh; Martin L Koser; Wendy A Cyr; Girish R Chopda; Junyan Tao; Xue Shui; Bo Ying; Dongyu Chen; Purva Pandya; Edmond Chipumuro; Zakir Siddiquee; Kevin Craig; Chengjung Lai; Henryk Dudek; Satdarshan P Monga; Weimin Wang; Bob D Brown; Marc T Abrams
Journal:  Mol Cancer Ther       Date:  2016-07-07       Impact factor: 6.261

3.  Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential.

Authors:  Srimeenakshi Srinivasan; Jenolyn F Alexander; Wouter H Driessen; Fransisca Leonard; Hu Ye; Xuewu Liu; Wadih Arap; Renata Pasqualini; Mauro Ferrari; Biana Godin
Journal:  J Mater Chem B       Date:  2013-10-21       Impact factor: 6.331

4.  The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice.

Authors:  Sjoerd Hak; Zuzana Garaiova; Linda Therese Olsen; Asbjørn Magne Nilsen; Catharina de Lange Davies
Journal:  Pharm Res       Date:  2014-10-28       Impact factor: 4.200

5.  Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle.

Authors:  Marc P Kai; Amanda W Keeler; Jillian L Perry; Kevin G Reuter; J Christopher Luft; Sara K O'Neal; William C Zamboni; Joseph M DeSimone
Journal:  J Control Release       Date:  2015-03-03       Impact factor: 9.776

6.  In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.

Authors:  Niravkumar R Patel; Aleksandr Piroyan; Srinivas Ganta; Allison B Morse; Katie M Candiloro; April L Solon; Abbegail H Nack; Corin A Galati; Collete Bora; Marisa A Maglaty; Shane W O'Brien; Samuel Litwin; Barbara Davis; Denise C Connolly; Timothy P Coleman
Journal:  Cancer Biol Ther       Date:  2018-05-08       Impact factor: 4.742

7.  Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Authors:  Olga B Garbuzenko; Maha Saad; Seema Betigeri; Min Zhang; Alexandre A Vetcher; Viatcheslav A Soldatenkov; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

8.  Size control of arsenic trioxide nanocrystals grown in nanowells.

Authors:  Eun-Ah You; Richard W Ahn; Min Hyung Lee; Meera R Raja; Thomas V O'Halloran; Teri W Odom
Journal:  J Am Chem Soc       Date:  2009-08-12       Impact factor: 15.419

Review 9.  Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.

Authors:  Xue-Qing Zhang; Xiaoyang Xu; Nicolas Bertrand; Eric Pridgen; Archana Swami; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2012-08-17       Impact factor: 15.470

10.  Giant unilamellar vesicles containing phosphatidylinositol(4,5)bisphosphate: characterization and functionality.

Authors:  Kévin Carvalho; Laurence Ramos; Christian Roy; Catherine Picart
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.